JESSICA KIRKPATRICK: Open Payments
NPI 1639724537 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 42 payments from 11 companies in 2025. Trend: 2023 $972 · 2024 $845 · 2025 $913
Food & beverage: $823Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $297 |
| MAYNE PHARMA COMMERCIAL LLC | 13 | $244 |
| ABBVIE INC. | 3 | $73 |
| Biogen, Inc. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| CooperSurgical, Inc. | 2 | $50 |
| Exeltis, USA Inc. | 2 | $35 |
| Organon LLC | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: Veozah, ZURZUVAE, Paragard T 380A, LILETTA, Mirena, SLYND, NEXPLANON, LO LOESTRIN FE.
Industry payments across NE — which companies pay providers there.
